INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
2.560
-0.170 (-6.23%)
At close: Aug 1, 2025, 4:00 PM
2.600
+0.040 (1.56%)
After-hours: Aug 1, 2025, 7:48 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
INKmune and DN-TNF Product Platform
155.00K
Log In
Log In
Log In
INKmune and DN-TNF Product Platform Growth
-58.56%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
United States
155.00K
Log In
Log In
Log In
United States Growth
-58.56%
Log In
Log In
Log In